Continuous low-dose temozolomide and celecoxib in recurrent glioblastoma

By Stockhammer Florian   Misch Martin   Koch Arend   Czabanka Marcus   Plotkin Michail   Blechschmidt Cristiane   Tuettenberg Jochen   Vajkoczy Peter  

Journal of Neuro-Oncology, Vol. 100, Iss. 3, 2010-12 ,pp. : 407-415

Springer Publishing Company

Access to resources Recommend Favorite

Nail alterations as a surrogate marker for the efficacy of low-dose metronomic chemotherapy

By            

Oncology Letters, Vol. 5, Iss. 4, 2013-01 ,pp. : 1123-1128

Spandidos Publications

Access to resources Recommend Favorite

Low-Dose Metronomic Paclitaxel Chemotherapy Suppresses Breast Tumors and Metastases in Mice

By Jiang Hongchi   Tao Weiyang   Zhang Mu   Pan Shangha   Kanwar Jagat R.   Sun Xueying  

Cancer Investigation, Vol. 28, Iss. 1, 2010-01 ,pp. : 74-84

Informa Healthcare

Access to resources Recommend Favorite

A phase II study of combined chemotherapy with methotrexate, 5-fluorouracil, and low-dose cisplatin (MFP) for histologically diffuse-type advanced and recurrent gastric cancer (KDOG9501)

By Nakayama Norisuke   Koizumi Wasaburo   Tanabe Satoshi   Sasaki Tohru   Saigenji Katsunori  

Gastric Cancer, Vol. 9, Iss. 3, 2006-08 ,pp. : 185-191

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of metronomic chemotherapy with bevacizumab for recurrent glioblastoma after progression on bevacizumab therapy

By Reardon David   Desjardins Annick   Peters Katherine   Gururangan Sridharan   Sampson John   Rich Jeremy   McLendon Roger   Herndon James   Marcello Jennifer   Threatt Stevie   Friedman Allan   Vredenburgh James   Friedman Henry  

Journal of Neuro-Oncology, Vol. 103, Iss. 2, 2011-06 ,pp. : 371-379

Springer Publishing Company

Access to resources Recommend Favorite